Figure 1.
(A) Response relative to time on CC‐223 treatment and (B) best percentage change from baseline in total length of target lesions were evaluated in 28 and 19 patients, respectively. Abbreviations: CRC, colorectal carcinoma; GBC, glioblastoma multiforme; HCC, hepatocellular carcinoma; MM, multiple myeloma; NET, (gastrointestinal) neuroendocrine tumor (of nonpancreatic origin); NSCLC, non–small cell lung cancer; RCC, renal cell carcinoma.